Abstract:We read with great interest the articles by Seijo and GarciaPagan, and Tripodi and Primignani recently published in Hepatology. We feel that these commentaries address an important and timely issue in patients with advanced liver disease, as they focus on the complex problem of hemostatic alterations in patients with cirrhosis, and on their possible therapeutic management. Indeed, patients with cirrhosis have a rebalanced coagulation equilibrium, although this balance is quite feeble and may be tipped either on the bleeding or on the thrombotic side by the occurrence of infections, derangement in renal function, and by the performance of invasive maneuvers. In order to correct the alterations of hematological and coagulation parameters, it is common practice among clinicians to order platelet or plasma transfusions, especially before invasive procedures. A recent survey has shown that, although patients with liver disease represented 7.7% of the inand out-patients receiving transfusions, they used 32% of administered plasma and 13% of the platelets. These findings are relevant because cirrhosis patients seldom obtain an adequate correction of thrombocytopenia with platelet transfusions and numerical improvement in prothrombin time requires transfusion of at least 2-6 units of fresh-frozen plasma. We feel that transfusing cirrhosis patients with several units of plasma to correct alteration in coagulation tests is not useful and may do harm by triggering portal hypertension-related bleeding. In fact, in 1974 Zimmon and Kessler found that the correlation between portal pressure and blood volume in cirrhosis patients was approximately linear. They demonstrated that every 100 mL of blood volume expansion, in a relatively short period of time, predicted a mean increase in portal pressure of 1.4 cm H20, equivalent to 1.03 mmHg. Using data obtained by the Holland and Brooks study, we found that to reach a target International Normalized Ratio (INR) value of 1.5 starting from various INR values (Table 1) required the transfusion of several liters of fresh-frozen plasma, and predicted an expected increase in portal pressure following transfusions that ranges from 15.5 to 25.8 mmHg. Reaching an INR target often reported as safe for invasive procedures or surgery in liver disease patients may actually paradoxically trigger bleeding. These data clearly show that research in the field of coagulation and liver disease should be fostered, and that the use of global coagulation tests such as thromboelastography should be further investigated as alternative measures in order to improve our management of patients with cirrhosis. EDOARDO G. GIANNINI, M.D., PH.D. R. TODD STRAVITZ, M.D. STEPHEN H. CALDWELL, M.D. Dipartimento di Medicina Interna Unit a di Gastroenterologia IRCCS-Azienda Ospedaliera Universitaria San Martino-IST Universit a di Genova Genova, Italy Section of Hepatology Division of Gastroenterology, Hepatology and Nutrition Hume-Lee Transplant Center Virginia Commonwealth University Richmond, VA, USA Division of Gastroenterology and Hepatology Digestive Health Center University of Virginia Charlottesville, VA, USA

Management of coagulopathy among patients with cirrhosis undergoing upper endoscopy and paracentesis: Persistent gaps and areas of consensus in a multispecialty Delphi

Reappraisal of the conventional hemostasis tests as predictors of perioperative bleeding in the era of rebalanced hemostasis in cirrhosis

Treating periprocedural bleeding in patients with cirrhosis

Association of Coagulopathy with the Risk of Bleeding after Invasive Procedures in Liver Cirrhosis

Guidelines for the management of coagulation disorders in patients with cirrhosis

Blood Conservation and Hemostasis in Cardiac Surgery: A Survey of Practice Variation and Adoption of Evidence-Based Guidelines

Technology: Is There Sufficient Evidence to Change Practice in Point-of-Care Management of Coagulopathy?

Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference

Cardiac Surgical Bleeding, Transfusion and Quality Metrics: Joint Consensus Statement by the Enhanced Recovery After Surgery Cardiac Society and Society for the Advancement of Patient Blood Management

A Multidisciplinary Pragmatic Protocol

Assessment and management of coagulopathy in critically-ill patients with liver failure

Adjuncts to Blood Component Therapies for the Treatment of Bleeding in the Intensive Care Unit

Association between isolated abnormal coagulation profile on transfusion following major surgery: A NSQIP analysis of individuals without bleeding disorders

A Perioperative Blood Management Algorithm Aimed at Conservation of Platelets in Clinical Practice: The Role of the Anesthesiologist in Decision-Making

Trial Sequence Meta-Analysis Can Reject False-Positive Result Calculated from Conventional Meta-Analysis

Point of care guided coagulation management in adult patients on ECMO: A systematic review and meta-analysis

Navigating Critical Waters: The Importance of a Systematic Coagulation Algorithm in the Intensive Care Unit

Managing anticoagulation and antiplatelet medications in GI endoscopy: a survey comparing the East and the West

Thromboelastography-guided vs. standard-of-care or on-demand platelet transfusion in patients with cirrhosis and thrombocytopenia undergoing procedures: A randomized controlled trial

Consensus Recommendations for Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding

Endoscopic management and outcome of non-variceal bleeding in patients with liver cirrhosis: A systematic review